News
December 2012

Federal Trade Commission Continues to Put a Spotlight on Pharmaceutical Patent Agreements

Intellectual Property & Technology Law Journal
By Barbara H. Wootton Matthew Shultz
Find more content tagged:

People

Barbara H. Wootton
Barbara H. Wootton
Counsel
Washington, DC
+1 202.942.6545
Email
VCard
Matthew Shultz
Matthew Shultz
Counsel
Washington, DC
+1 202.942.6147
Email
VCard

Related Content

June 18, 2021
Fed. Circ. Raytheon Ruling Shifts Obviousness Analysis
Aerospace & Defense Law360, Appellate Law360, Intellectual Property Law360, Massachusetts Law360, Technology Law360
May 25, 2021
Strategic Applications of ITC Admin Law Judge Pilot Program
Intellectual Property Law360, International Trade Law360, Public Policy Law360
May 5, 2021
The Curious Cases of Trade Secret Identification
Thomson Reuters
Subscribe
Subscribe Link

Email Disclaimer

Reject Accept